This study checks how safe and effective guselkumab is for treating Psoriatic Arthritis (*PsA*), a type of arthritis that causes joint swelling. Guselkumab is given as a shot under the skin. To join, participants must have active PsA and have not responded well to usual treatments like drugs or biologics. They should not have rheumatoid factors, which are proteins found in some people with arthritis. Participants also need to be checked for Tuberculosis (TB), a lung disease, to make sure they don't have it. Women should have a negative pregnancy test to participate.
- Study Length: Participation duration is not mentioned.
- Risks: Potential side effects and infection risks due to immune system changes.
- Compensation: Not specified if there's any financial benefit for joining.
Before joining, participants should ensure they meet all the requirements and consider any risks involved. Always discuss with a doctor before participation.
How understandable was the trial content above?
Hard to understand
Easy to understand